About the journal
RSC Pharmaceutics is an open-access journal published by The Royal Society of Chemistry in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,200 GBP. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- The Royal Society of Chemistry
- ISSN
- 2976-8713
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,200 GBP
- Articles in DOAJ
- 22
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
Index listings
- DOAJ · 2024-09-19
- PUBMED · 2024-04-18
- Indexing
- DOAJ · PUBMED
- APC
- 2,200 GBP
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
22
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
313
Last recorded publication year
2026
h-index
18
i10-index
50
From OpenAlex open data (CC0).
Editorial & policy11
- Added to DOAJ
- 2024-09-19
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 79%
- ORCID iDs in current deposits
- 79%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918803387106676
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Advanced Drug Delivery Systems
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
Show all subjects (50)
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
- Mathematics, Computing, and Information Processing
- Mathematics, Computing, and Information Processing
- Inhalation and Respiratory Drug Delivery
- Lipid Membrane Structure and Behavior
- Inhalation and Respiratory Drug Delivery
- Lipid Membrane Structure and Behavior
- Electrospun Nanofibers in Biomedical Applications
- Biotechnology and Related Fields
- Cell Image Analysis Techniques
- Biotechnology and Related Fields
- Hydrogels: synthesis, properties, applications
- Cell Image Analysis Techniques
- Crystallization and Solubility Studies
- Crystallization and Solubility Studies
- Wound Healing and Treatments
- Electrospun Nanofibers in Biomedical Applications
- Wound Healing and Treatments
- Nanoparticles: synthesis and applications
- 3D Printing in Biomedical Research
- Nanoparticles: synthesis and applications
- 3D Printing in Biomedical Research
- Hydrogels: synthesis, properties, applications
- Advanced biosensing and bioanalysis techniques
- Supramolecular Self-Assembly in Materials
- Photodynamic Therapy Research Studies
- Photodynamic Therapy Research Studies
- Supramolecular Self-Assembly in Materials
- Advanced biosensing and bioanalysis techniques
- Dermatology and Skin Diseases
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Innovative Microfluidic and Catalytic Techniques Innovation
- Dermatology and Skin Diseases
- Innovative Microfluidic and Catalytic Techniques Innovation
Keywords (DOAJ)
- pharmaceutical sciences
- drug delivery
- drug formulation
- drug efficacy
- biomedical sciences
- pharmaceutics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ